NTRA

Natera, Inc.

Nasdaq · Services-Medical Laboratories · Inc. DE · CIK 0001604821
$213.47 -0.85% $30.6B
Insider Selling Cluster (5 insiders)High Impact Filing (7/10)3 New Institutional Positions
Vol
Market Cap$30.6B
Cap SizeLarge Cap
Analyst ConsensusStrong Buy (89%)
Inst. Holders10 funds
Inst. Value$4.4B
Inst. Activity3 buys / 1 sells
Insider Activity0B / 31S
Insider Net $-$11.3M
Reddit Sentiment50° Neutral
SEC Reports19
Exchange Nasdaq·Sector Services-Medical Laboratories·Inc. DE·CIK 0001604821·Prev Close $215.31

Recent Activity

Jun 10, 2026 SEC
A cluster of four NTRA insiders, including the CEO and a director, sold a total of ~$7.0M in open-market sales over a 5-
CLUSTER — Impact 2/10
Jun 9, 2026 SEC
Thomas J. Lynch Jr. filed a Form 3 initial statement of beneficial ownership upon becoming a reporting person at Natera,
3 — Impact 2/10
Jun 6, 2026 SEC
Three NTRA insiders, including the CEO and director, collectively sold $6.34M in open-market sales over a 4-day window.
CLUSTER — Impact 3/10
Jun 5, 2026 Insider
Marcus Gail Boxer sold 11,000 shares
Director @ $0.00 ($0.00)
Jun 5, 2026 Insider
Marcus Gail Boxer sold 3,016 shares
Director @ $216.06 ($651.6K)
Jun 5, 2026 Insider
Marcus Gail Boxer sold 11,000 shares
Director @ $22.83 ($251.1K)
Inst.
NORGES BANK — NEW
1,625,553 shares ($372.4M)
Inst.
FMR LLC — ADD
1,475,988 shares ($338.1M)

Price Targets

$259.26 +16.4% upside Buy
Current $222.82 Low $193.00 Median $265.00 High $300.00 19 analysts
$193.00 $300.00

Analyst Ratings

Strong Buy89% buy · 27 analysts
11Strong Buy
13Buy
3Hold
0Sell
0Strong Sell
Recent Analyst Actions
DateFirmActionRating
Jun 5, 2026 Goldman Sachs INITIATE Buy → Neutral
May 11, 2026 BTIG MAINTAIN Buy → Buy
May 8, 2026 JP Morgan MAINTAIN Overweight → Overweight
May 8, 2026 Evercore ISI Group MAINTAIN Outperform → Outperform
May 8, 2026 Wells Fargo MAINTAIN Equal-Weight → Equal-Weight

Earnings Estimates

PeriodEPS Est.RangeGrowth#
Current Q $-0.52 ▲ +2.5% $-0.76 — $-0.30 29% YoY 13
Next Q $-0.36 ▲ +19.2% $-0.59 — $-0.24 44% YoY 12
Current FY $-1.68 ▲ +9.4% $-2.34 — $-1.24 -10% YoY 14
Next FY $-0.30 ▲ +56.5% $-2.37 — $1.32 82% YoY 14

Top Institutional Holders

FundValueMove
VANGUARD GROUP INC$2.8B
NORGES BANK$372.4MNEW
FMR LLC$338.1MADD
MORGAN STANLEY$282.7M
BANK OF AMERICA CORP$200.5MADD

Recent Insider Trades

DateInsiderTypeValue
Jun 5, 2026Marcus GailM$0.00
Jun 5, 2026Marcus GailSELL$651.6K
Jun 5, 2026Marcus GailM$251.1K
Jun 4, 2026Chapman StevenSELL$176.7K
Jun 1, 2026BOTHA ROELOFSELL$5.8M

Reddit Sentiment

50°
Neutral
Bearish Neutral Bullish
2 mentions 0 bullish 0 bearish
10 institutional holders with $4.4B total value (21,546,860 shares) as of 2025-Q4. Top holders: VANGUARD, NORGES, FMR. Net buying activity: 3 institutions added/increased vs 1 reduced.

Top Institutional Holders — 2025-Q4

#FundSharesValue% of TrackedLast Move
1VANGUARD GROUP INC12,306,424$2.8B64.6%
2NORGES BANK1,625,553$372.4M8.5%NEW
3FMR LLC1,475,988$338.1M7.8%ADD +32.6%
4MORGAN STANLEY1,234,154$282.7M6.5%
5BANK OF AMERICA CORP /DE/875,373$200.5M4.6%ADD +27.0%
6CHARLES SCHWAB INVESTMENT MANAGEMENT INC674,403$154.5M3.5%TRIM -33.3%
7WELLS FARGO & COMPANY/MN384,768$88.1M2.0%ADD +33.0%
8TWO SIGMA INVESTMENTS, LP268,240$61.5M1.4%DOUBLED +230.2%
9RENAISSANCE TECHNOLOGIES LLC190,600$43.7M1.0%TRIM -36.1%
10Duquesne Family Office LLC2,511,357$575.3K0.0%

Recent Position Changes

FundActionPrev SharesCurr SharesChange %ValueQuarter
NORGES BANKNEW1,625,553$372.4M2025-Q4
FMR LLCADD1,113,3461,475,988+32.6%$338.1M2025-Q4
WELLS FARGO & COMPANY/MNADD289,310384,768+33.0%$88.1M2025-Q4
RENAISSANCE TECHNOLOGIES LLCTRIM298,500190,600-36.1%$43.7M2025-Q4
BANK OF AMERICA CORP /DE/ADD599,333761,305+27.0%$122.5M2025-Q3
CHARLES SCHWAB INVESTMENT MANAGEMENT INCTRIM971,091647,361-33.3%$104.2M2025-Q3
RENAISSANCE TECHNOLOGIES LLCTRIM493,800298,500-39.6%$48.0M2025-Q3
WELLS FARGO & COMPANY/MNADD194,788289,310+48.5%$46.6M2025-Q3
NORGES BANKEXIT1,644,0680-100.0%$0.002025-Q3
NORGES BANKNEW1,644,068$277.7M2025-Q2
RENAISSANCE TECHNOLOGIES LLCADD347,700493,800+42.0%$83.4M2025-Q2
TWO SIGMA INVESTMENTS, LPDOUBLED76,445252,444+230.2%$42.6M2025-Q2
CITADEL ADVISORS LLCADD1,652,8682,373,358+43.6%$335.6M2025-Q1
UBS Group AGDOUBLED168,460357,356+112.1%$50.5M2025-Q1
WELLS FARGO & COMPANY/MNDOUBLED96,136207,146+115.5%$29.3M2025-Q1
TWO SIGMA INVESTMENTS, LPNEAR_EXIT374,36576,445-79.6%$10.8M2025-Q1
NORGES BANKEXIT1,415,2850-100.0%$0.002025-Q1
CITADEL ADVISORS LLCTRIM2,366,4581,652,868-30.2%$261.6M2024-Q4
WELLS FARGO & COMPANY/MNADD55,79696,136+72.3%$15.2M2024-Q4
CHARLES SCHWAB INVESTMENT MANAGEMENT INCNEW802,534$101.9M2024-Q3
15 unique insiders with 31 transactions. Net insider value: -$11.3M ($0.00 bought, $11.3M sold).

Insider Transactions

DateInsiderTitleTypeSharesPriceValue
Jun 5, 2026Marcus Gail BoxerDirectorM11,000$0.00$0.00
Jun 5, 2026Marcus Gail BoxerDirectorSELL3,016$216.06$651.6K
Jun 5, 2026Marcus Gail BoxerDirectorM11,000$22.83$251.1K
Jun 4, 2026Chapman Steven LeonardCEO AND PRESIDENTSELL832$212.42$176.7K
Jun 1, 2026BOTHA ROELOFDirectorSELL26,411$218.69$5.8M
Jun 1, 2026Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICSSELL1,802$217.52$392.0K
May 29, 2026Rubin Eric HDirectorA2,124$0.00$0.00
May 26, 2026Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICSSELL1,652$202.84$335.1K
May 26, 2026Fesko JohnPRESIDENT, CHIEF BUS. OFFICERSELL1,438$202.84$291.7K
May 13, 2026Sheena JonathanDirectorSELL85$199.52$17.0K
May 8, 2026Sheena JonathanDirectorSELL200$205.43$41.1K
May 5, 2026Rabinowitz MatthewEXECUTIVE CHAIRMANSELL2,887$206.77$596.9K
May 5, 2026Rabinowitz MatthewEXECUTIVE CHAIRMANA2,389$0.00$0.00
May 4, 2026Brophy Michael BurkesCHIEF FINANCIAL OFFICERSELL482$210.49$101.5K
May 4, 2026Rabinowitz MatthewEXECUTIVE CHAIRMANSELL722$206.16$148.8K
May 1, 2026Fesko JohnPRESIDENT, CHIEF BUS. OFFICERSELL291$206.16$60.0K
May 1, 2026Chapman Steven LeonardCEO AND PRESIDENTSELL902$206.16$186.0K
May 1, 2026RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICERSELL330$206.16$68.0K
May 1, 2026Sheena JonathanDirectorSELL107$206.16$22.1K
May 1, 2026Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICSSELL405$206.16$83.5K
May 1, 2026Brophy Michael BurkesCHIEF FINANCIAL OFFICERSELL313$206.16$64.5K
Apr 29, 2026Sheena JonathanDirectorSELL2,266$196.22$444.6K
Apr 29, 2026Brophy Michael BurkesCHIEF FINANCIAL OFFICERSELL300$190.12$57.0K
Apr 27, 2026Fesko JohnPRESIDENT, CHIEF BUS. OFFICERSELL771$203.75$157.1K
Apr 27, 2026Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICSSELL997$203.75$203.1K
Apr 27, 2026RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICERSELL873$203.75$177.9K
Apr 27, 2026Sheena JonathanDirectorSELL285$203.75$58.1K
Apr 27, 2026Chapman Steven LeonardCEO AND PRESIDENTSELL2,272$203.75$462.9K
Apr 27, 2026Brophy Michael BurkesCHIEF FINANCIAL OFFICERSELL771$203.75$157.1K
Apr 24, 2026ROSENMAN HERMDirectorA117$0.00$0.00
Apr 24, 2026Marcus Gail BoxerDirectorA108$0.00$0.00
Apr 24, 2026Chapman Rowan EDirectorA114$0.00$0.00
Apr 24, 2026BOTHA ROELOFDirectorA132$0.00$0.00
Apr 24, 2026Rubin Eric HDirectorA5$0.00$0.00
Apr 24, 2026Williams Brinkley RuthDirectorA86$0.00$0.00
Apr 24, 2026Bertagnolli MonicaDirectorA83$0.00$0.00
Apr 24, 2026Baynes Roy D.DirectorA83$0.00$0.00
Apr 17, 2026Sheena JonathanDirectorSELL750$199.66$149.7K
Apr 6, 2026Rabinowitz MatthewEXECUTIVE CHAIRMANM58,292$0.00$0.00
Apr 6, 2026Rabinowitz MatthewEXECUTIVE CHAIRMANF27,610$204.87$5.7M
Apr 6, 2026Rabinowitz MatthewEXECUTIVE CHAIRMANM58,292$9.59$559.0K
Apr 1, 2026RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICERSELL300$200.79$60.2K
Apr 1, 2026Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICSSELL1,048$201.32$211.0K
Mar 31, 2026Rabinowitz MatthewEXECUTIVE CHAIRMANM41,708$9.59$400.0K
Mar 31, 2026Rabinowitz MatthewEXECUTIVE CHAIRMANM41,708$0.00$0.00
Mar 20, 2026Sheena JonathanDirectorSELL239$198.85$47.5K
Mar 18, 2026Sheena JonathanDirectorSELL300$196.27$58.9K
Mar 16, 2026Rabinowitz MatthewEXECUTIVE CHAIRMANSELL100$190.07$19.0K
Mar 16, 2026Rabinowitz MatthewEXECUTIVE CHAIRMANM50,000$0.00$0.00
Mar 16, 2026Rabinowitz MatthewEXECUTIVE CHAIRMANM50,000$9.59$479.5K
19 SEC filing reports analyzed. Sentiment: 1 bullish, 1 bearish, 0 mixed, 17 neutral. Avg impact: 3.5/10.
NEUTRAL CLUSTER 2/10
A cluster of four NTRA insiders, including the CEO and a director, sold a total of ~$7.0M in open-ma
Jun 10, 2026
NEUTRAL 3 2/10
Thomas J. Lynch Jr. filed a Form 3 initial statement of beneficial ownership upon becoming a reporti
Jun 9, 2026
NEUTRAL CLUSTER 3/10
Three NTRA insiders, including the CEO and director, collectively sold $6.34M in open-market sales o
Jun 6, 2026
NEUTRAL CLUSTER 3/10
Three Natera insiders sold a total of $6.46M in open-market sales over a 7-day window, led by Direct
Jun 4, 2026
NEUTRAL CLUSTER 2/10
Three Natera insiders sold a total of $6.40M in stock over a 7-day window, led by Director Roelof Bo
Jun 3, 2026
NEUTRAL CLUSTER 3/10
Two C-suite executives at Natera (President/Chief Business Officer and President of Clinical Diagnos
May 29, 2026
NEUTRAL CLUSTER 3/10
Seven Natera insiders, including the Executive Chairman, CEO, and CFO, sold a total of ~$1.14M in op
May 16, 2026
NEUTRAL CLUSTER 3/10
Seven insiders sold a total of $670K in open-market sales over a 5-day window, representing less tha
May 7, 2026
NEUTRAL CLUSTER 3/10
Six Natera insiders, including the CEO and CFO, sold a total of ~$1.39M in open-market sales over a
May 6, 2026
NEUTRAL CLUSTER 3/10
Two C-suite executives at Natera (President of Clinical Diagnostics and President/Chief Business Off
Apr 30, 2026
NEUTRAL CLUSTER 3/10
Natera executives sold $271K in shares over a 7-day window, including a $211K sale by President Solo
Apr 9, 2026
NEUTRAL CLUSTER 3/10
Two Natera insiders sold shares in a recent 7-day window, including the President of Clinical Diagno
Apr 4, 2026
NEUTRAL CLUSTER 3/10
Natera's Executive Chairman Matthew Rabinowitz exercised options for 100,000 shares and sold a small
Mar 21, 2026
BEARISH CLUSTER 7/10
Natera's Executive Chairman Matthew Rabinowitz exercised and sold shares following a series of deriv
Mar 18, 2026
NEUTRAL CLUSTER 4/10
Natera's Executive Chairman Matthew Rabinowitz exercised options for 300,000 shares and sold 25,228
Mar 17, 2026
NEUTRAL CLUSTER 5/10
Multiple Natera executives and a director sold shares in a coordinated open-market transaction total
Mar 12, 2026
NEUTRAL CLUSTER 4/10
Multiple Natera insiders, including the Chief Legal Officer and President/Chief Business Officer, so
Mar 12, 2026
NEUTRAL CLUSTER 4/10
Natera executives, including CEO Steven Chapman, sold shares in the open market, with total proceeds
Mar 4, 2026
BULLISH INST-CLUSTER 7/10
Three major institutions — Fidelity, Wells Fargo, and Norges Bank — collectively added $572.9M in ne
Feb 28, 2026

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Current analyst consensus: Strong Buy (89% buy). Based on 27 analysts: 11 strong buy, 13 buy, 3 hold, 0 sell, 0 strong sell.

Analyst Price Targets

$259.26 mean target +16.4% upside Buy (1.50)
$193.00 Low $300.00 High
MetricValue
Current Price$222.82
Target Low$193.00
Target Mean$259.26
Target Median$265.00
Target High$300.00
# Analysts19
RecommendationBuy (1.50)

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
2026-06-30
$-0.52 $-0.76 $-0.30 29.3% +2.5% 7↑ 3↓ $0.7B 20.8% 13
Next Q
2026-09-30
$-0.36 $-0.59 $-0.24 43.6% +19.2% 7↑ 2↓ $0.7B 17.4% 12
Current FY
2026-12-31
$-1.68 $-2.34 $-1.24 -10.4% +9.4% 10↑ 3↓ $2.8B 21.3% 14
Next FY
2027-12-31
$-0.30 $-2.37 $1.32 82.4% +56.5% 9↑ 4↓ $3.3B 18.1% 14

Current Quarter EPS Revision History

TimepointEPS EstimateChange
Current$-0.523
7d ago$-0.509-0.015
30d ago$-0.536+0.013
60d ago$-0.543+0.020
90d ago$-0.541+0.018
12 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 3 initiations.

Individual Analyst Actions

DateAnalyst FirmActionPrevious RatingNew Rating
Jun 5, 2026 Goldman Sachs INITIATE Buy Neutral
May 11, 2026 BTIG MAINTAIN Buy Buy
May 8, 2026 JP Morgan MAINTAIN Overweight Overweight
May 8, 2026 Evercore ISI Group MAINTAIN Outperform Outperform
May 8, 2026 Wells Fargo MAINTAIN Equal-Weight Equal-Weight
Apr 14, 2026 William Blair INITIATE Outperform
Mar 3, 2026 Morgan Stanley MAINTAIN Overweight Overweight
Feb 27, 2026 Wells Fargo MAINTAIN Equal-Weight Equal-Weight
Feb 27, 2026 Evercore ISI Group MAINTAIN Outperform Outperform
Feb 27, 2026 Baird MAINTAIN Outperform Outperform
Jan 7, 2026 Citigroup INITIATE Buy
Jan 5, 2026 Guggenheim MAINTAIN Buy Buy
Dec 22, 2025 Canaccord Genuity MAINTAIN Buy Buy
Dec 15, 2025 Barclays MAINTAIN Overweight Overweight
Dec 15, 2025 JP Morgan MAINTAIN Overweight Overweight
Dec 15, 2025 Wells Fargo MAINTAIN Equal-Weight Equal-Weight

Monthly Consensus History

PeriodStrong BuyBuyHoldSellStrong SellBuy %Distribution
Jun 1, 2026111330089%
May 1, 2026111430089%
Apr 1, 2026101530089%
Mar 1, 2026101530089%
Feb 1, 202691530089%
Jan 1, 202691530089%
Strong BuyBuyHoldSellStrong Sell

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

50°
Neutral
Bearish Neutral Bullish
2 mentions 0 bullish 0 bearish 2 time periods

Reddit Sentiment History

DateMentionsSentimentBullishBearishThreads
May 26, 2026144° Neutral001
May 26, 2026144° Neutral001

Recent Reddit Threads

r/wallstreetbets Neutral 14d 8h ago
place for stock picks that are not used for calls or puts? Higher risk growth picks?
▲ 1 💬 0 ⚡ 0.5
May 18, 2026
dark_pool
Dark Pool: NTRA — 2.6M shares, 53,611 trades
Week starting 2026-05-18. Total ATS volume: 2,590,147 shares across 53,611 trades.
May 11, 2026
dark_pool
Dark Pool: NTRA — 2.9M shares, 46,207 trades
Week starting 2026-05-11. Total ATS volume: 2,923,831 shares across 46,207 trades.
May 7, 2026
earnings_calendar
NTRA Q1 2026 Earnings After Market Close — 2026-05-07
May 4, 2026
dark_pool
Dark Pool: NTRA — 3.7M shares, 51,991 trades
Week starting 2026-05-04. Total ATS volume: 3,732,160 shares across 51,991 trades.
Apr 27, 2026
dark_pool
Dark Pool: NTRA — 1.6M shares, 33,243 trades
Week starting 2026-04-27. Total ATS volume: 1,615,603 shares across 33,243 trades.
Apr 22, 2026
short_volume
Short Volume: NTRA — 55.3% short (0.3M / 0.6M)
Short: 307,738 | Exempt: 9 | TRF Vol: 556,176 | Short Ratio: 55.3% | Off-exchange volume (dark pool + OTC)
Apr 20, 2026
dark_pool
Dark Pool: NTRA — 1.4M shares, 30,179 trades
Week starting 2026-04-20. Total ATS volume: 1,363,175 shares across 30,179 trades.
Apr 13, 2026
dark_pool
Dark Pool: NTRA — 2.7M shares, 48,540 trades
Week starting 2026-04-13. Total ATS volume: 2,724,918 shares across 48,540 trades.
Apr 6, 2026
dark_pool
Dark Pool: NTRA — 2.3M shares, 39,853 trades
Week starting 2026-04-06. Total ATS volume: 2,259,746 shares across 39,853 trades.
Apr 1, 2026
short_volume
Short Volume: NTRA — 60.1% short (0.4M / 0.7M)
Short: 395,587 | Exempt: 21 | TRF Vol: 658,481 | Short Ratio: 60.1% | Off-exchange volume (dark pool + OTC)
Mar 31, 2026
short_interest
FTD: NTRA — 83,324 shares ($15.6M) failed to deliver
Settlement: 20260331, Price: $186.84, FTD Value: $15,568,256.16, NATERA INC COM
Mar 31, 2026
short_volume
Short Volume: NTRA — 59.2% short (0.3M / 0.6M)
Short: 339,834 | Exempt: 237 | TRF Vol: 574,401 | Short Ratio: 59.2% | Off-exchange volume (dark pool + OTC)
Mar 30, 2026
dark_pool
Dark Pool: NTRA — 1.6M shares, 31,927 trades
Week starting 2026-03-30. Total ATS volume: 1,600,377 shares across 31,927 trades.
Mar 23, 2026
dark_pool
Dark Pool: NTRA — 1.3M shares, 33,020 trades
Week starting 2026-03-23. Total ATS volume: 1,281,156 shares across 33,020 trades.
Mar 16, 2026
dark_pool
Dark Pool: NTRA — 1.6M shares, 37,639 trades
Week starting 2026-03-16. Total ATS volume: 1,561,529 shares across 37,639 trades.